Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-22-0302
Abstract: Abstract Activating mutations in mitogen-activated protein kinase kinase 1 (MAP2K1) are involved in a variety of cancers and may be classified according to their RAF dependence. Sensitivity to combined BRAF and MEK treatments is associated…
read more here.
Keywords:
map2k1 variants;
evaluation;
sensitivity;
braf ... See more keywords